Ayaz Ahmed Memon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ayaz Ahmed Memon has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Ayan Bin Rafaih
Education Department, Aitchison College, Lahore, Pakistan
2 shared publications - Irshad Shaikh
Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK
2 shared publications - Muhammad Rafaih Iqbal
Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK
2 shared publications - Abdelrahman Abdelaal
Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK
1 shared publication - Aryan Raj Goel
St Richard’s Hospital, University Hospitals Sussex NHS Foundation Trust, Chichester, UK
1 shared publication - Joachim Cheng En Ho
College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK
1 shared publication
Latest Publications
- 1 September 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-8
Comparing surgical outcomes of robotic and laparoscopic or open ileal pouch–anal anastomosis: a systematic review and meta-analysis
Restorative proctocolectomy with ileal pouch–anal anastomosis (IPAA) is the standard surgical approach for patients with ulcerative colitis (UC) or familial adenomatous polyposis (FAP) seeking bowel continuity. While laparoscopy improves recovery, robotic-assisted surgery may offer advantages in pelvic procedures. However, its comparative efficacy remains unclear. This systematic review followed PRISMA guidelines to compare short-term outcomes of robotic-assisted IPAA with laparoscopic and open techniques. Literature was searched across PubMed, Embase, Web of Science, and the Cochrane Library for studies from January 2000 to June 2025. Included studies compared adult patients (≥ 18 years) undergoing IPAA for malignancy, UC or FAP. Primary outcomes were operative time, blood loss, hospital stay, and complications; secondary outcomes included conversion to open surgery, readmission, and reoperation. Meta-analysis was performed using pooled odds ratios, mean difference and 95% confidence intervals. Ten studies including 3,166 patients met inclusion criteria. Robotic IPAA was associated with a shorter length of stay (WMD − 1.1 days, 95% CI − 1.8 to − 0.3) and a non-significant trend toward fewer conversions to open surgery (OR 0.33, 95% CI 0.10–1.13). However, robotic procedures had longer operative times. Estimated blood loss did not differ significantly, and no significant differences were found in postoperative complications, anastomotic leaks, readmissions, or reoperations. Robotic-assisted IPAA is a safe and viable alternative to laparoscopic and open surgery, offering benefits in shorter hospital stay and conversion rates. Although operative times are longer, morbidity is comparable. Further prospective studies are needed to confirm these findings and evaluate long-term functional outcomes.
- 1 September 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-8
Comparing surgical outcomes of robotic and laparoscopic or open ileal pouch–anal anastomosis: a systematic review and meta-analysis
Restorative proctocolectomy with ileal pouch–anal anastomosis (IPAA) is the standard surgical approach for patients with ulcerative colitis (UC) or familial adenomatous polyposis (FAP) seeking bowel continuity. While laparoscopy improves recovery, robotic-assisted surgery may offer advantages in pelvic procedures. However, its comparative efficacy remains unclear. This systematic review followed PRISMA guidelines to compare short-term outcomes of robotic-assisted IPAA with laparoscopic and open techniques. Literature was searched across PubMed, Embase, Web of Science, and the Cochrane Library for studies from January 2000 to June 2025. Included studies compared adult patients (≥ 18 years) undergoing IPAA for malignancy, UC or FAP. Primary outcomes were operative time, blood loss, hospital stay, and complications; secondary outcomes included conversion to open surgery, readmission, and reoperation. Meta-analysis was performed using pooled odds ratios, mean difference and 95% confidence intervals. Ten studies including 3,166 patients met inclusion criteria. Robotic IPAA was associated with a shorter length of stay (WMD − 1.1 days, 95% CI − 1.8 to − 0.3) and a non-significant trend toward fewer conversions to open surgery (OR 0.33, 95% CI 0.10–1.13). However, robotic procedures had longer operative times. Estimated blood loss did not differ significantly, and no significant differences were found in postoperative complications, anastomotic leaks, readmissions, or reoperations. Robotic-assisted IPAA is a safe and viable alternative to laparoscopic and open surgery, offering benefits in shorter hospital stay and conversion rates. Although operative times are longer, morbidity is comparable. Further prospective studies are needed to confirm these findings and evaluate long-term functional outcomes.
- Open Access
- 16 July 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-28
Robotic Beyond Total Mesorectal Excision (bTME) for locally advanced and recurrent anorectal cancer: a systematic review
Robotic surgery is increasingly utilized for rectal cancer resection, particularly in cases requiring beyond total mesorectal excision (bTME) to achieve oncological clearance. Despite longer operative times, robotic bTME has been associated with reduced morbidity and blood loss, making it an emerging approach in specialized centers. A systematic review following PRISMA guidelines was conducted in Web of Science, PubMed, and Scopus. Studies reporting robotic bTME for recurrent or locally advanced anorectal cancer were included. Outcomes assessed included study characteristics, demographics, operative outcomes, oncological data, and follow-up. Nineteen studies comprising 1027 patients met the inclusion criteria (13 case series—68% and 6 cohort studies—32%). The median patient age ranged from 51 to 68 years with 73.7% males. Most patients had an ASA score of 2 (53.1%), and BMI ranged from 21.1 to 28.6. Tumor locations were predominantly near the anal verge (median: 3–6 cm), and the most common clinical staging was cT3, cN1, and cM0. Surgical complications included urinary issues (22.6%), anastomotic leakage (11.4%), ileus (10.4%), and bleeding (5.3%). Follow-up data indicated a recurrence rate of 24.9%, and the 1-year survival rate was > 90%. These studies reported an overall complication rate of 49.7%, with a median follow-up of 12–36 months. Oncological outcomes were favorable, although there was significant variability in survival data between studies. The heterogenicity of the studies makes it challenging to conclusively establish robotic bTME as a feasible alternative to the gold standard. Further prospective studies, with measurable outcomes and consistent terminology, are needed to ensure homogeneity.
- 16 July 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-28
Open AccessRobotic Beyond Total Mesorectal Excision (bTME) for locally advanced and recurrent anorectal cancer: a systematic review
Robotic surgery is increasingly utilized for rectal cancer resection, particularly in cases requiring beyond total mesorectal excision (bTME) to achieve oncological clearance. Despite longer operative times, robotic bTME has been associated with reduced morbidity and blood loss, making it an emerging approach in specialized centers. A systematic review following PRISMA guidelines was conducted in Web of Science, PubMed, and Scopus. Studies reporting robotic bTME for recurrent or locally advanced anorectal cancer were included. Outcomes assessed included study characteristics, demographics, operative outcomes, oncological data, and follow-up. Nineteen studies comprising 1027 patients met the inclusion criteria (13 case series—68% and 6 cohort studies—32%). The median patient age ranged from 51 to 68 years with 73.7% males. Most patients had an ASA score of 2 (53.1%), and BMI ranged from 21.1 to 28.6. Tumor locations were predominantly near the anal verge (median: 3–6 cm), and the most common clinical staging was cT3, cN1, and cM0. Surgical complications included urinary issues (22.6%), anastomotic leakage (11.4%), ileus (10.4%), and bleeding (5.3%). Follow-up data indicated a recurrence rate of 24.9%, and the 1-year survival rate was > 90%. These studies reported an overall complication rate of 49.7%, with a median follow-up of 12–36 months. Oncological outcomes were favorable, although there was significant variability in survival data between studies. The heterogenicity of the studies makes it challenging to conclusively establish robotic bTME as a feasible alternative to the gold standard. Further prospective studies, with measurable outcomes and consistent terminology, are needed to ensure homogeneity.